| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,153,847 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$3,153,847 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-05-11 |
4 |
AS |
$45.00 |
$562,500 |
D/D |
(12,500) |
19,114 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-08-08 |
4 |
AS |
$45.00 |
$562,500 |
D/D |
(12,500) |
19,396 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-07-24 |
4 |
AS |
$59.29 |
$592,900 |
D/D |
(10,000) |
15,041 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-03 |
4 |
OE |
$39.87 |
$598,050 |
D/D |
15,000 |
47,476 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-11-01 |
4 |
AS |
$49.54 |
$619,245 |
D/D |
(12,500) |
19,396 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-24 |
4 |
AS |
$71.01 |
$639,090 |
D/D |
(9,000) |
7,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-02-01 |
4/A |
AS |
$52.50 |
$656,260 |
D/D |
(12,500) |
19,114 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-05-01 |
4 |
AS |
$22.26 |
$666,606 |
D/D |
(29,945) |
2,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-04-30 |
4 |
AS |
$22.51 |
$675,153 |
D/D |
(30,000) |
2,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-03 |
4 |
AS |
$46.77 |
$701,600 |
D/D |
(15,000) |
32,476 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-21 |
4 |
OE |
$47.34 |
$762,789 |
D/D |
16,113 |
81,867 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-21 |
4 |
S |
$49.29 |
$794,211 |
D/D |
(16,113) |
65,754 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-10-18 |
4 |
AS |
$65.00 |
$796,250 |
D/D |
(12,250) |
15,041 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-11-09 |
4 |
AS |
$34.08 |
$856,605 |
D/D |
(22,805) |
10,803 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-14 |
4 |
OE |
$47.34 |
$1,070,452 |
D/D |
22,612 |
74,364 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-14 |
4 |
S |
$49.21 |
$1,121,195 |
D/D |
(22,612) |
65,754 |
0 |
% |
|
191 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
